NSEBSE
There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.Open1,145
High1,152.8
Low1,138
Prev. Close1,143.8
Avg. Traded Price1,143.98
Volume1,13,640
MARKET DEPTH
Total bid1,38,628.00
Total ask1,81,552.00
| Orders | Qty | Bid |
|---|
| 2 | 366 | 1140.8 |
| 2 | 50 | 1140.7 |
| 1 | 1 | 1140.6 |
| 10 | 290 | 1140.5 |
| 6 | 446 | 1140.4 |
| Ask | Qty | Orders |
|---|
| 1141.2 | 2 | 43 |
| 1141.3 | 5 | 88 |
| 1141.4 | 4 | 34 |
| 1141.5 | 8 | 127 |
| 1141.6 | 5 | 175 |
HIGH/LOW
LOW/HIGH
₹1,138.0020 minutes ago
₹1,152.80an hour ago
Motilal Oswal Nifty Midcap 100 ETF
Motilal Oswal Nifty Midcap 150 Index Fund-Reg(G)
UTI Healthcare Fund-Reg(IDCW)
3Y Return+24.8%
NAV₹214.01
UTI Large & Mid Cap Fund-Reg(G)
3Y Return+23.9%
NAV₹174.52
UTI Aggressive Hybrid Fund-Reg(G)
3Y Return+18.5%
NAV₹398.62
Aurobindo Pharma Limited continues to be one of the world’s fastest growing Active Pharmaceutical Ingredients (API) manufacturing companies, driven by cost leadership, flexibility to produce multiple products in the same manufacturing facilities and capabilities in various therapeutic domains. Its API business has ensured the profitability and growth of its formulations business through seamless vertical integration. Its API business is supported by technologically advanced research and development infrastructure, which develops new products and plays a role in the delivery of products to the market. It has built a strong presence in key therapeutic segments such as Central nervous system (CNS), cardiovascular (CVS), anti-retroviral (ARV), anti-diabetics, gastroenterology and antibiotics. Also, it is building a diversified pipeline in high-margin specialty generic formulations segment.
